A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/10/2011	US20110275686 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110274762 Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
11/10/2011	US20110274761 Polymer carrier
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274759 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/10/2011	US20110274758 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/10/2011	US20110274757 Nucleic acid delivery vehicle and uses thereof
11/10/2011	US20110274756 Method and membrane for tissue regeneration
11/10/2011	US20110274755 Supportive treatment of liver disease
11/10/2011	US20110274754 Oral tablet compositions of dexlansoprazole
11/10/2011	US20110274753 Dual release oral tablet compositions of dexlansoprazole
11/10/2011	US20110274752 Modified release pharmaceutical compositions of dexlansoprazole
11/10/2011	US20110274751 Trimetazidine formulation with different release profiles
11/10/2011	US20110274750 Enteric formulation of duloxetine and its core and prepration method
11/10/2011	US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
11/10/2011	US20110274748 CAI-Based Systems and Methods for the Localized Treatment of Ocular and Other Diseases
11/10/2011	US20110274747 C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
11/10/2011	US20110274746 Therapeutic Liposomes and Methods For Producing and Using the Same
11/10/2011	US20110274745 Instillation of liposomal formulation of sirna and antisense oligonucleotides
11/10/2011	US20110274744 Process for preparing a surface coated by crosslinked polyelectrolyte multilayer films as a biomimetic reservoir for proteins
11/10/2011	US20110274743 Medicament for the Treatment of Pain and Inflammation
11/10/2011	US20110274742 Cartilage Repair Systems and Applications Utilizing A Glycosaminoglycan Mimic
11/10/2011	US20110274741 Ingestible compositions and processes of preparation
11/10/2011	US20110274739 Methods for governing tissue growth
11/10/2011	US20110274737 Implantable materials having engineered surfaces and method of making same
11/10/2011	US20110274735 Taste potentiator compositions and edible confectionery and chewing gum products containing same
11/10/2011	US20110274734 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274733 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
11/10/2011	US20110274732 Medical device loaded with formulation for targeted delivery of biologically active material/s and method of manufacture thereof
11/10/2011	US20110274731 Production Method Of Fine O/W Emulsion External Preparation
11/10/2011	US20110274730 Biosurfactant composition produced by a new bacillus licheniforms strain, uses and products thereof
11/10/2011	US20110274729 Implantable compositions for repairing osteochondral defects
11/10/2011	US20110274728 Compositions and Methods for Alleviating Hyposalivation and for Providing Oral Comfort
11/10/2011	US20110274727 Depigmenting topical compositions and their uses
11/10/2011	US20110274726 Chitosan foam medical devices and methods
11/10/2011	US20110274725 Decomposable biocompatible hydrogels and system and method for using same
11/10/2011	US20110274724 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
11/10/2011	US20110274712 Antigenic compositions
11/10/2011	US20110274682 Methods for protease assisted protein delivery
11/10/2011	US20110274676 Topical Use Of Probiotic Bacillus Spores To Prevent Or Control Microbial Infections
11/10/2011	US20110274628 Nicotine-containing pharmaceutical compositions
11/10/2011	US20110274627 Method Of Making An Aerosol Shave Composition Comprising A Hydrophobical Agent Forming At Least One Microdroplet
11/10/2011	US20110274625 Liposomal Composition for Convection-Enhanced Delivery to the Central Nervous Centre
11/10/2011	US20110274622 Nanocrystal Nano-Emulsion
11/10/2011	US20110274621 Active Particles for Bio-Analytical Applications and Methods for Their Preparation
11/10/2011	US20110274620 Multifunctional degradable nanoparticles with control over size and functionalities
11/10/2011	US20110274619 Brain tumor targeting peptides and methods
11/10/2011	US20110272276 Implant with antimicrobial coating
11/10/2011	DE102010028826A1 Producing microcapsules, useful to incorporate active substance in cosmetics, comprises combining organic phase of epoxide and hydrophobic active substance, with water phase of water and compound reactive with the epoxide and polymerizing
11/10/2011	DE102010019416A1 Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum Orodispersible tablet comprising a triptan or an atypical antipsychotic
11/10/2011	CA2798923A1 Novel ophthalmic compositions
11/10/2011	CA2798151A1 Immunogen adherence and method of making and using same
11/10/2011	CA2798145A1 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
11/10/2011	CA2798116A1 Topical pharmaceutical composition comprising heparin
11/10/2011	CA2795105A1 Pharmaceutical formulations comprising pioglitazone and linagliptin
11/10/2011	CA2795030A1 Novel low concentration meloxicam tablets
11/10/2011	CA2794309A1 Layered drug delivery device
11/10/2011	CA2793571A1 Propynylaminoindan transdermal compositions
11/10/2011	CA2776482A1 Compositions, gels and foams with rheology modulators and uses thereof
11/10/2011	CA2739751A1 Pharmaceutical compositions comprising hydromorphone and naloxone
11/09/2011	EP2384769A2 Ophthalmic visualization compositions and methods of using same
11/09/2011	EP2384768A1 Phenylpropionamide compounds and the use thereof
11/09/2011	EP2384754A1 Pharmaceutical dosage forms
11/09/2011	EP2384748A2 Method of forming fibers
11/09/2011	EP2384747A2 Oral Tablet Compositions Of Dexlansoprazole
11/09/2011	EP2384746A2 Dual release oral tablet compositions of dexlansoprazole
11/09/2011	EP2384745A2 Modified Release Pharmaceutical Compositions Of Dexlansoprazole
11/09/2011	EP2384744A1 Lipid-based dispersions useful for drug delivery
11/09/2011	EP2384743A1 Siosomal formulation for intracellular delivery and targeting of therapeutic agents
11/09/2011	EP2384742A1 Pharmaceutical excipient, method for its preparation and use thereof
11/09/2011	EP2384623A1 Powder composition for the prevention and treatment of animal hoof diseases
11/09/2011	EP2384312A2 Water clusters, products with water clusters, and methods of producing
11/09/2011	EP2384198A2 Pharmaceutical compositions and methods of treating neurological insults
11/09/2011	EP2384190A2 Formulations of viable cells for oral delivery
11/09/2011	EP2384188A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
11/09/2011	EP2384114A1 Nutraceuticals containing nitro fatty acids
11/09/2011	EP2010189B1 Osmotic drug delivery system comprising release enhancing agent
11/09/2011	EP1789021B1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
11/09/2011	EP1773452B1 Lysis / resealing process for incorporating an active ingredient in erythrocytes
11/09/2011	EP1383516B1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/09/2011	EP1343508B1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	CN202027942U Veterinary tablet capable of adjusting feeding dosage
11/09/2011	CN1985799B Preparing process for oral disintegrated preparation
11/09/2011	CN1984675B Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose
11/09/2011	CN1957900B Edible and medicinal anti-crinkle cosmetic of Chinese traditional medicine containing composite collagen, amino acid, and vitamin, and preparation method
11/09/2011	CN1935194B Preparation method of Chinese medicine composition for treating nephroma
11/09/2011	CN1931232B Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process
11/09/2011	CN1931219B Gynostemma pentaphylla micro emulsion medicine and its preparation
11/09/2011	CN1913924B Solid sustained-releasing formulation comprising triptorelin acetate
11/09/2011	CN1899339B Medicinal composition for treating acute and chronic conjunctivitis for eye and its preparing method
11/09/2011	CN102239431A Ophthalmic devices for delivery of hydrophobic comfort agents
11/09/2011	CN102238964A Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
11/09/2011	CN102238958A Inhalant comprising modified superoxide dismutase
11/09/2011	CN102238946A Pharmaceutical composition for the controlled release of methylphenidate
11/09/2011	CN102238945A Pharmaceutical formulation 514
11/09/2011	CN102238944A A method for the production of bioadhesive compact matrices
11/09/2011	CN102238943A Solid microstructure that enables multiple controlled release and method of manufacturing same
11/09/2011	CN102238942A Improvements relating to pharmaceutical compositions

1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 2991